SABCS 2016: The Search for an Effective and Safe PI3K-Inhibitor
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...